Dr. Terence Rhodes, MD
Claim this profileIntermountain Cancer Center- Saint George Cancer Center
Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
3 drugs studied
Area of expertise
1Skin Cancer
Stage IV
BRAF positive
Stage III
2Melanoma
Stage IV
BRAF positive
MSI-H positive
Affiliated Hospitals
Clinical Trials Terence Rhodes, MD is currently running
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting1 award Phase 29 criteria
VO + Nivolumab
for Advanced Melanoma
This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment for patients with unresectable Stage IIIb-IV cutaneous melanoma whose disease progressed on an anti PD-1 and an anti-CTLA-4 containing regimen (administered either as a combination regimen or in sequence) or who are not candidates for treatment with an anti-CTLA-4 therapy.
Recruiting2 awards Phase 33 criteria
More about Terence Rhodes, MD
Clinical Trial Related8 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Terence Rhodes, MD has experience with
- Nivolumab
- RP1
- Vusolimogene Oderparepvec
Breakdown of trials Terence Rhodes, MD has run
Melanoma
Colorectal polyposis syndrome
Microsatellite Instability
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Terence Rhodes, MD specialize in?
Terence Rhodes, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Terence Rhodes, MD currently recruiting for clinical trials?
Yes, Terence Rhodes, MD is currently recruiting for 2 clinical trials in Saint George Utah. If you're interested in participating, you should apply.
Are there any treatments that Terence Rhodes, MD has studied deeply?
Yes, Terence Rhodes, MD has studied treatments such as Nivolumab, RP1, Vusolimogene Oderparepvec.
What is the best way to schedule an appointment with Terence Rhodes, MD?
Apply for one of the trials that Terence Rhodes, MD is conducting.
What is the office address of Terence Rhodes, MD?
The office of Terence Rhodes, MD is located at: Intermountain Cancer Center- Saint George Cancer Center, Saint George, Utah 84790 United States. This is the address for their practice at the Intermountain Cancer Center- Saint George Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.